Early this month, CVS agreed to pay nearly $38M to settle five related whistleblower cases concerning its dispensing of insulin pens. The government and many whistleblowers alleged that CVS improperly requested and received reimbursement for premature refills, dispensed more insulin pens than patients needed according to their prescriptions, and falsely under-reported the days-of-supply of insulin […]








